Acessibilidade / Reportar erro

First report of vancomycin-resistant Enterococcus faecalis in Uberaba, Minas Gerais state

Abstract

In this study we report the first isolation of VanA-type vancomycin-resistant Enterococcus faecalis strains from two different patients hospitalized in the same intensive care unit at the hospital of Universidade Federal do Triângulo Mineiro (UFTM), Uberaba, Minas Gerais, Brazil.

vancomycin resistance; Enterococcus faecalis; vanA genotyping


MEDICAL

First report of vancomycin-resistant Enterococcus faecalis in Uberaba, Minas Gerais state

Natália ConceiçãoI; Ana Lúcia da Costa DariniII; Izabel Cristina Vanzato PalazzoII; Cristina da Cunha Hueb Barata de OliveiraI; Adriana Gonçalves de OliveiraI,* * Corresponding Author. Mailing address: Universidade Federal do Triângulo Mineiro, Departamento de Ciências Biológicas, Disciplina de Microbiologia, Praça Manoel Terra, 330, 38015-050, Uberaba, MG, Brasil.; Tel.: (34) 3318-5480 Fax: (34) 3318-5462.; E-mail: agoliveira@dcb.uftm.edu.br

IUniversidade Federal do Triângulo Mineiro, Uberaba, MG, Brasil

IIFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil

ABSTRACT

In this study we report the first isolation of VanA-type vancomycin-resistant Enterococcus faecalis strains from two different patients hospitalized in the same intensive care unit at the hospital of Universidade Federal do Triângulo Mineiro (UFTM), Uberaba, Minas Gerais, Brazil.

Key words: vancomycin resistance; Enterococcus faecalis; vanA genotyping

Vancomycin-resistant enterococci (VRE) have emerged as important nosocomial pathogens worldwide in the last two decades, particularly in USA (3). In Brazil, the frequency of VRE isolation in hospitals has also increasing significantly, since the first report in 1998 (6).

Glycopeptide resistance in enterococci is associated with a variety of phenotypes but VanA-type VRE is the most prevalent in Brazil (9). VRE strains with this phenotype express high-level resistance to vancomycin and teicoplanin and harbored a mobile genetic element Tn1546 that carries vanA gene cluster responsible by glycopeptide resistance (5).

In this study we report the first isolation of VanA-type VRE strains from two different patients hospitalized in the ICU at the hospital of the Universidade Federal do Triângulo Mineiro (UFTM), Uberaba, Minas Gerais, Brazil.

The first VRE strain was isolated on March 11th, 2006, from an abdominal aorta catheter of a patient who underwent abdominal aortic aneurysmectomy. This patient, a 74-year-old male, was admitted to the hospital on March 5th, 2006, for the surgery. Postoperatively, he stayed in ICU for three days and was treated prophylactically with cephalothin. One day after left the ICU, he died by broncoaspiration. The second VRE strain was isolated on April 3rd, 2006, from a tracheal secretion of a 60-year-old male who was hospitalized since January, 2006, with pneumonia. In February, as the patient developed urinary tract infection and septic shock, he was transferred to ICU. He remained at ICU for fifty-nine days. This patient recovered and left the hospital at the end of April. Prior to isolation of VRE, the patient had been treated with ciprofloxacin, ampicillin/sulbactam, cefepim, imipenem/cilastin and vancomycin. These two patients were hospitalized in the same room in the ICU-adult for a period of three days in common.

The isolates were identified to species level by conventional biochemical tests (8). Minimum inhibitory concentration (MIC) for vancomycin was determined by broth dilution test and susceptibility to ampicillin, penicillin, ciprofloxacin, chloramphenicol, erythromycin, gentamycin, streptomycin, tetracycline and teicoplanin was performed by disk diffusion method (4). E. faecalis ATCC 29212 and E. faecalis ATCC 51299 were used as controls.

Genomic DNA of the microorganisms was extracted by mechanical disruption of cells (1). Polymerase chain reaction (PCR) was performed in order to confirm phenotypic species level identification (7) and multiplex PCR to determine the van genotype (13). Control strains were Enterococcus casseliflavus NCTC 12361, E. faecium NCTC 7171, E. faecalis NCTC 775, E. gallinarum NCTC 12359, and E. faecium BM 4147 vanA genotype.

Tn1546-like elements and vanRSHAX regions were amplified by Long-PCR (L-PCR) according to Palepou et al. (10) using the Long PCR Enzyme Mix (Fermentas, Glen Burnie, MD, USA). First, a single primer (P1) complementary to the inverted repeats regions flanking the transposon was used for amplified Tn1546-like elements. Subsequently, the amplified Tn1546-like element was the template for L-PCR of vanRSHAX genes using primers P2 and P3. The L-PCR products were analysed on 1% agarose gel.

Isolates were typed by pulsed-field gel electrophoresis (PFGE) after SmaI-digestion of DNA (2) in a Gene Navigator apparatus (Amersham, Uppsala, Sweden) at 180V for 25h, at 7ºC with pulses of 20s for 10h, 8s for 10h and 3s for 5h. DNA banding patterns were analysed using previously described criteria (12).

Both VRE isolates were identified as Enterococcus faecalis and expressed high-level resistance to vancomycin (MIC > 256 µg/ml). They showed the same antimicrobial susceptibility profile, characterized by resistance to ciprofloxacin, chloramphenicol, erythromycin, tetracycline and teicoplanin. The isolates showed susceptibility to ampicillin, penicillin, gentamicin and streptomycin.

According to multiplex PCR assay both VRE isolates harbored the vanA gene in the intact Tn1546-like element. The vanRSHAX genes were also detected by Long-PCR.

The molecular typing has disclosed the same PFGE pattern for both isolates (Fig. 1), suggesting clonal dissemination of this strain in ICU. On the other hand, we founded seven different bands comparing the PFGE profile of these VRE strains, isolated in 2006, with the clone predominant spread in some states of Brazil (strains isolated from 1998 to 2000) (9). As the criteria proposed by Tenover et al. (12) for analyzing the relationship among strains refer to those obtained for a short period of time, the difference in PFGE profile could not signify that they are unrelated.


In Minas Gerais state, the prevalence of VRE seems to be lower than that observed in other states, such as São Paulo and Rio Grande do Sul, since there is only one other report describing the isolation of a VRE strain in the Uberlândia city in 2003 (11).

In conclusion, our data showed that the VRE was transferred horizontally between patients in the same ICU room emphasizing that is very important to monitor their occurrence in hospital environment and to take measures to prevent the dissemination of nosocomial VRE among several patients.

ACKNOWLEDGMENTS

The authors thank Joseane Cristina Ferreira for technical assistance during the PFGE assays. This work was supported by a grant from the Fundação de Ensino e Pesquisa de Uberaba (FUNEPU).

Submitted: December 01, 2008; Returned to authors for corrections: June 15, 2009; Approved: July 24, 2009.

  • 1. Bolano, A.; Stinchi, S.; Preziosi, R.; Bistoni, F.; Allegrucci, M.; Baldelli, F.; Martini, A.; Cardinali, G. (2001). Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res., 1: 221-224.
  • 2. Campanile, F.; Bartoloni, A.; Bartalesi, F.; Borbone, S.; Mangani, V.; Mantella, A.; Nicoletti, G.; Paradisi, F.; Russo, G.; Strohmeyer, M.; Stefani, S. (2003). Molecular alterations of VanA element in vancomycin-resistant enterococci isolated during a survey of colonized patients in an Italian intensive care unit. Microb. Drug Resist., 9: 191-199.
  • 3. Cetinkaya, Y.; Falk, P.; Mayhall, C.G. (2000). Vancomycin-Resistant Enterococci. Clin. Microbiol. Rev., 13: 686-707.
  • 4. CLSI-Clinical Laboratory Standards Institute. (2007). Performance standards for antimicrobial susceptibility testing. 15th Informational Supplement M100-S17, Wayne, PA.
  • 5. Courvalin, P. (2006). Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis., 42: 25-34.
  • 6. Dalla Costa, L.M.; Souza, D.C.; Martins, L.T.F.; Zanella, R.C.; Brandileone, M.C.; Bokermann, S.; Sader, H.S.; Souza, H.A.P.H.M. (1998). Vancomycin-resistant Enterococcus faecium: first case in Brazil. Braz. J. Infect Dis., 2:160-163.
  • 7. Dutka-Malen S.; Evers, S.; Courvalin, P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol., 33: 24-27.
  • 8. Facklam, R.R.; Sahm, D.F.; Teixeira, L.M. (1999). Enterococcus. Manual of clinical microbiology, 7nd ed., American Society for Microbiology, Washington, 297-305.
  • 9. Palazzo, I.C.V.; Camargo, I.L.B.C.; Zanella, R.C.; Darini, A.L.C. (2006). Evaluation of clonality in enterococci isolated in Brazil carrying Tn1546-like elements associated with vanA plasmids. FEMS Microbiol. Lett., 258: 29-36.
  • 10. Palepou, M.F.I.; Adebiyi, A.M.A.; Tremlett, C.H.; Jensen, L.B.; Woodford, N. (1998). Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci. J. Antimicrob. Chemother. 42: 605-612.
  • 11. Ribas, R.M.; Darini, A.L.C.; Moreira, T.A.; Freitas, C.; Gontijo Filho, P.P. (2007). Vancomycin-resistant VanA phenotype Enterococcus faecalis: first case in Minas Gerais state and epidemiological considerations. Braz. J. Infec. Dis. 11: 439-440.
  • 12. Tenover, F.C.; Arbeit, R.D.; Goering, R.V.; Mickelsen, P.A.; Murray, B.E.; Persing, D.H.; Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33: 2233-2239.
  • 13. Woodford, N.; Morrison, D.; Johnson, A.P.; Briant, V.; George, R.C.; Cookson, B. (1993). Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J. Clin. Microbiol., 31: 653-658.
  • *
    Corresponding Author. Mailing address: Universidade Federal do Triângulo Mineiro, Departamento de Ciências Biológicas, Disciplina de Microbiologia, Praça Manoel Terra, 330, 38015-050, Uberaba, MG, Brasil.; Tel.: (34) 3318-5480 Fax: (34) 3318-5462.; E-mail:
  • Publication Dates

    • Publication in this collection
      23 Nov 2009
    • Date of issue
      Mar 2010

    History

    • Reviewed
      15 June 2009
    • Received
      01 Dec 2008
    • Accepted
      24 July 2009
    Sociedade Brasileira de Microbiologia USP - ICB III - Dep. de Microbiologia, Sociedade Brasileira de Microbiologia, Av. Prof. Lineu Prestes, 2415, Cidade Universitária, 05508-900 São Paulo, SP - Brasil, Ramal USP 7979, Tel. / Fax: (55 11) 3813-9647 ou 3037-7095 - São Paulo - SP - Brazil
    E-mail: bjm@sbmicrobiologia.org.br